Genesis Ibrc India Ltd

Meeting Details

• Board meeting scheduled for August 29, 2026; time and venue not disclosed.

Key Agenda Items

• Increase in Authorised Share Capital and alteration of MOA Clause V.
• Fund-raising via preferential issue of equity shares or other securities, subject to approvals.
• Sub-division of share capital, subject to shareholders and authorities' approvals.
• Directors' Report with annexures for year ended March 31, 2026.
• Acquisition of entities and related matters.
• Shift in registered office and related matters.
• Fix date, time, venue, and mode of AGM; approve Notice.
• Fix cut-off date and Book Closure for AGM and final dividend entitlement.
• Appoint Scrutinizer and Remote E-voting Agency for AGM.

Other Notes

New appointment

• Ami Oza appointed as Additional Independent Non-Executive Director and Chair, effective Aug 21, 2026.
• Appointment for five years, subject to shareholders' approval; not liable to retire by rotation.
• Profile: LL.M., BLS/LL.B., IPR diploma; 10+ years in corporate and regulatory law.
• Not related to other directors or KMPs.
• Not debarred by SEBI; not disqualified under Companies Act 2013.

Chairperson resignation

• Ritika Agrawal resigned as Chairperson of the Board, effective Aug 21, 2026.
• Continuing as Independent Non-Executive Director.

Board and committee reconstitution

• Patel ceased as Independent Non-Executive Director due to sad demise; Aug 15, 2026.
• Ami Oza appointed Additional INED w.e.f Aug 21, 2026.
• Ritika Agrawal appointed Audit Committee Chair from Aug 21, 2026.
• Ami Oza appointed Audit Committee Member from Aug 21, 2026.
• Patel ceased as NRC Chair and member; Aug 15, 2026.
• Ritika Agrawal appointed NRC Chair from Aug 21, 2026.
• Ami Oza appointed NRC Member from Aug 21, 2026.
• Patel ceased as Audit Committee Chair and member; Aug 15, 2026.
• Patel ceased as SRC Chair; Aug 15, 2026.
• Ritika Agrawal appointed SRC Chair from Aug 21, 2026.
• Ami Oza appointed SRC Member from Aug 21, 2026.

Demise of INED

• Ashok Chhaganbhai Patel, Independent Non-Executive Director, CCME Global Limited.
• Cessation as INED due to death, effective August 15, 2026.
• DIN: 08024669.
• Annexure A records death reason and cessation date.
• Impact on governance: cessation of INED status.

Q1 FY2026-27 results

• Approved unaudited standalone results for quarter ended 30-Jun-2026.
• Revenue from operations: 0.00 Rs lakh; total revenue: 0.05 Rs lakh; other income: 0.05 Rs lakh.
• Loss before tax and after tax: -26.42 Rs lakh; basic/diluted EPS: (0.06).
• Total expenses: 26.47 Rs lakh; key components: employee benefits 6.69, depreciation 2.31, other expenses 17.47.
• Internal auditors appointed: M/s G J M S & Associates LLP for FY2026-27.
• Company operates in a single segment; restatement of prior year figures due to Ind AS 116/109.

Meeting Details

• Board meeting on August 14, 2026 in Mumbai; exact time not disclosed.

Key Agenda Items

• Consider and approve unaudited financial results with Limited Review Report for Q1 ended June 30, 2026.

Other Notes

• No additional notes disclosed in this filing.

Statutory Auditor Appointment

• Desai Saksena & Associates appointed as statutory auditors to fill vacancy after M. S. Rao & Associates resignation.
• Date of appointment: July 15, 2026; term until AGM on/before Sep 30, 2026, subject to approval.
• Firm profile: established 1984; 40+ years in statutory audits and advisory.
• Reason: fill casual vacancy due to resignation of previous auditor.
• Disclosure of relationships: Not Applicable.

Managing Director Remuneration

• Board approved remuneration of INR 80,000 per month to Ms. Poonam Chaturvedi as MD.
• Effective from July 1, 2026 to March 31, 2027.
• Subject to shareholders' approval; recommendation by Nomination & Remuneration Committee.
• Details of prior appointment remain unchanged.

Key Decisions

• Appointed Desai Saksena & Associates as statutory auditors on July 15, 2026 to fill the casual vacancy.
• Term until the AGM on or before September 30, 2026, subject to shareholder approval.
• Remuneration approved for MD Ms. Poonam Chaturvedi at INR 80,000 per month.
• MD appointment term: July 1, 2026 to March 31, 2027; details unchanged.

Other Approvals

• Trading window closed from July 1, 2026 until 48 hours after Q1 2026 results.

Dematerialisation confirmation and depository update

• Dematerialised securities were mutilated, cancelled after verification; NSDL/CDSL updated as registered owners within 15 days.
• Details of dematerialised securities furnished to stock exchanges.